Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-08

Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of intravenous infusion of cultured allogeneic umbilical cord-derived mesenchymal stem cells for osteoporosis has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord-derived Mesenchymal Stem Cell Infusion (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Osteoporosis | Phase 1 | Status: WITHDRAWN